InflaRx N.V (IFRX)

NASDAQ

$1.56

$+0.02

(+1.30%)

After-Hours

InflaRx N.V (IFRX) Live Price Chart

Last updated: ⁦2026-10-21 20:39:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

InflaRx N.V (IFRX) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.56, with a market capitalization of $213.68M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.80 to $2.95. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$213.68M
Open	$1.55
Day's High	$53.10
Day's Low	$0.71
Previous Close	$1.54
Volume	697.07K
Average Volume	792.09K
P/E Ratio	--
52-Week High	$2.95
52-Week Low	$0.80
Dividend Yield	--
Earnings Date	--

InflaRx N.V (IFRX) After-Hours Stock Price

InflaRx N.V (IFRX) is trading at $1.56 in after-hours trading as of 2026-10-21 19:59:51, up 0.97% ($0.01) from the regular-session close of $1.54.

After-hours trading shows how investors are pricing IFRX after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.

InflaRx N.V (IFRX) 7-Day Stock Price Change

Over the past seven days, InflaRx N.V (IFRX) moved from $1.59 to $1.56, representing a decline of 2.14% ($0.03).

The stock traded between $1.29 and $1.64 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.

The average daily volume was 1.01 million shares, up versus the previous seven-day period, indicating higher trading activity.

IFRX 52-Week Price Position

Position in Range: 35.2%

52W Low$0.80

52W High$2.95

IFRX is currently trading at $1.56, placing it 35.2% of the way from its 52-week low of $0.80 to its 52-week high of $2.95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is InflaRx N.V (IFRX)?

InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

InflaRx N.V Information

Employees	65
Exchange	NASDAQ
Company Website	https://www.inflarx.de

How to Buy InflaRx N.V (IFRX) Stock on MEXC

Eligible investors can buy real shares of InflaRx N.V (IFRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for IFRX and Place Your Order

Open the RealStocks trading page and search for IFRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is InflaRx N.V (IFRX) stock price today?

InflaRx N.V (IFRX) is currently trading at $ 1.56, up 1.04% ($0.02) from the previous close of $ 1.54. Intraday prices update in real time during regular trading hours.

2.Is IFRX stock going up or down today?

As of 2026-10-21 19:59:51, IFRX is trading at $ 1.56, up 1.04% ($0.02) from its previous close of $ 1.54. The stock has traded between $ 0.71 and $ 53.10 during today’s regular session. Past price movements do not guarantee future results.

3.What is IFRX pre-market price?

As of 2026-10-21 19:59:51, IFRX is trading at $ 1.53 in pre-market trading, down 0.58% ($0.01) from the previous close of $ 1.54. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is IFRX after-hours price?

As of 2026-10-21 19:59:51, IFRX is trading at $ 1.56 in after-hours trading, up 0.97% ($0.01) from the regular-session close of $ 1.54. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is IFRX stock trading now?

IFRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does IFRX sit relative to its 52-week high and low?

Over the past 52 weeks, IFRX has traded between a low of $ 0.80 and a high of $ 2.95. At $ 1.56, the stock is positioned 35.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is InflaRx N.V in?

InflaRx N.V (IFRX) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is InflaRx N.V's market capitalization and where is it listed?

InflaRx N.V is listed on the NASDAQ exchange with a market capitalization of $ 213.68M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is IFRX valued in terms of P/E ratio and EPS?

IFRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does InflaRx N.V pay a dividend?

InflaRx N.V pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.